Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Insulin Resistance in Adolescent Depression
NCT05571878Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2021
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of human insulin in major depressive disorder (MDD), sponsored by Center for Addiction and Mental Health. Primary endpoint: Change in brain imaging outcomes measuring brain insulin resistance. Started Sep 2021; status: completed.
02
Drugs
human insulin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05571878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05571878.